Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02831998 · ClinicalTrials.gov registry record · Phase 3

In-vivo Efficacy of Patient Preoperative Prep

A Phase 3 study of Surgical Skin Preparation, sponsored by Zurex Pharma.

Completed
Registry status
Phase 3
Development phase
440
Enrollment target
1
Study location

NCT02831998 is a Phase 3 study of Surgical Skin Preparation that has completed, run by Zurex Pharma. The registered enrollment target is 440 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02831998, a Phase 3 study of Surgical Skin Preparation, has completed, sponsored by Zurex Pharma.

COMPLETED
Registry status
Phase 3
Development phase
440 participants
Enrollment target
1
Study location

Study Summary

The objective of the study is to demonstrate the antimicrobial efficacy of the ZP Preoperative Prep on skin flora of the abdomen and inguinal regions of human subjects.

Conditions Studied

Interventions

  • DRUG ZuraPrep
  • DRUG ChloraPrep
  • DRUG ZP Vehicle

Study Locations (1)

Virginia

  • MicroBioTest Laboratories - Sterling

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2016-07-27
Est. Completion 2017-04-09
Phase Phase 3

Sponsor

Zurex Pharma

9 total trials

What the Registry Record Tells You About NCT02831998

The ClinicalTrials.gov registry entry for NCT02831998 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zurex Pharma, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgical Skin Preparation appearing as the primary indexed condition, and to 3 interventions - of which ZuraPrep is the first listed.

NCT02831998 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT02831998 about?

NCT02831998 is a clinical study titled "In-vivo Efficacy of Patient Preoperative Prep". The objective of the study is to demonstrate the antimicrobial efficacy of the ZP Preoperative Prep on skin flora of the abdomen and inguinal regions of human subjects.

What is the current status of trial NCT02831998?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 440 participants. The study started on 2016-07-27. Estimated completion is 2017-04-09.

What conditions does trial NCT02831998 study?

This clinical trial studies the following conditions: Surgical Skin Preparation.

What interventions are being tested in trial NCT02831998?

The interventions under investigation include: ZuraPrep (DRUG), ChloraPrep (DRUG), ZP Vehicle (DRUG).

Who is sponsoring clinical trial NCT02831998?

This trial is sponsored by Zurex Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02831998 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Skin Preparation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.